The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Open accessThe DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Abstract
Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the possible relationship between Alzheimer’s Disease (AD) pathogenesis and progression, the diagnostic and therapeutic potential of approaches aiming at restoring gut microbiota eubiosis remain to be fully addressed. In this narrative review, we briefly summarize the role of gut microbiota homeostasis in brain health and disease, and we present evidence for its dysregulation in AD patients. Based on these observations, we then discuss how dysbiosis might be exploited as a new diagnostic tool in early and advanced disease stages, and we examine the potential of prebiotics, probiotics, fecal microbiota transplantation, and diets as complementary therapeutic interventions on disease pathogenesis and progression, thus offering new insights into the diagnosis and treatment of this devastating and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the successful use of FMT in the treatment of refractory or recurrent Clostridium difficile infection, several studies have been conducted to explore FMT as a therapeutic strategy for a wide range of neurological disorders, including multiple sclerosis, epilepsy, ASD, Tourette syndrome, diabetic neuropathy, AD and PD, with promising preclinical and clinical data [30,465,466,467,468].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“GM-based biomarkers have recently been considered as promising early and prodromal diagnostic tools in various neurological diseases, such as multiple sclerosis, AD and PD itself [30,156,157]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“• Through incoming and outgoing branches of the vagus nerve [26], which represents the major modulatory pathway [27].”
BackgroundParada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · cited 1×
“As mentioned, another beneficial role exerted by the gut microbiota is the production of SCFAs, including butyrate, propionate, and acetate, essential for energy production, gut epithelia homeostasis, and immune regulation [83].”
BackgroundFormation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the composition of a “healthy microbiota” has not yet been defined, a balanced environment between the host and microorganisms is known to be essential to carry on the necessary immunological and metabolic functions [58].”
BackgroundPathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · cited 1×
“This alteration, in turn, may affect the CNS through the modulation of stress hormones [28].”
Background
Cited by
Items 201–239 of 239
Blood Biomarkers for Alzheimer’s Dementia Diagnosis
Park, C.-E. (2022) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2022.54.4.249
The Gut Microbiome: Unveiling its Potential Role in Dementia Risk
Filatov, A. (2023) · SVOA Neurology · doi:10.58624/svoane.2023.04.0112
“[7] However, more rigorous research is warranted to establish causality, delineate specific microbial signatures associated with dementia, and identify effective therapeutic targets.”
Relação entre doenças inflamatórias intestinais atividade física e doenças neurodegenerativas
Fernandes, I. D. C., dos Santos, B. W., Miguel, I. D., Dalarmi, L., Montrucchio, D. P., Dias, J. D. F. G., Miguel, M. D., & Miguel, O. G. (2023) · Revista Cereus · doi:10.18605/2175-7275/cereus.v15n4p319-334
Ghorbani, M., Ferreira, D., & Maioli, S. (2023) · Figshare · doi:10.6084/m9.figshare.24012951
Sharma, L., & Sharma, D. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00039 · Cited by 3
The Scenario of Emerging Gut Microbiome Cross Talks in Brain Aging
Panneerselvam, S., Jayaraman, S., & Rajagopal, P. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_2
Gut-Microbiota as a Therapeutic Intervention for Cognitive Damage
Hamdalla, H. M., Abdul‐Hamid, M., & Zaky, M. Y. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_11
Martins, G. C. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-29102024-165307
Zhabinskaya, A. A., Melik-Kasumov, T. B., & Pyzh, H. E. (2024) · Proceedings of the National Academy of Sciences of Belarus Medical series · doi:10.29235/1814-6023-2024-21-4-334-344
Future prospective of microbiome-gut brain axis for treatment of CNS disorders
Mane, R., Kashid, S., Mazahir, F., & Yadav, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00019-5
Understanding Psychoneuroimmunology in Pediatric Development: A Focus on Neurodivergent Populations
Rajan, A. V., & Alexander, A. E. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch006
The role of gut microbiota in pathogenesis of Alzheimer Disease.
Barzyk, K., Gołębiowska, W., Gryta, N., Brodowska, A., Cieślik-Porębska, M., Kondratowicz, M., Kurek, M., & Chrościńska–Krawczyk, M. (2025) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/210031
The gut microbiome in neurodegeneration: A metagenomics and bioinformatics perspective
Muthukumar, G., Goyal, S., & Saraboji, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29932-2.00006-2
Host–Microbiota Interactions in Endocrine Diseases
Pakmehr, A., Siadat, S. D., & Ejtahed, H. (2025) · Springer eBooks · doi:10.1007/978-981-95-2286-6_8
Wang, L., Yu, L., Li, J., Wang, H., Zhang, Z., Fu, Z., Yu, H., Cui, Y., & Han, L. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108177
Consales, A., Toscano, L., Ceriotti, C., Tiraferri, V., Castaldi, S., & Giannì, M. L. (2024) · Figshare · doi:10.6084/m9.figshare.25591333
Ghorbani, M., Ferreira, D., & Maioli, S. (2023) · Figshare · doi:10.6084/m9.figshare.24012954
Eje intestino-cerebro: modificaciones de la microbiota intestinal en enfermedades priónicas.
De Diego Abejón, P., Martín Burriel, I., & López, L. G. (2024) · Zaguan (Universidad de Zaragoza)
Engineering the Gut Microbiome for Metabolic, Reproductive, and Cognitive Health
Maissy, E. S. (2024) · eScholarship (California Digital Library)
Connell, E. (2025) · UEA Digital Repository (University of East Anglia) · Cited by 1
Cabezas Calvente, P. (2023) · Institutional Repository of the University of Granada (University of Granada)
Ren, D., Xiang, C., Chai, X., Zhang, Z., Zhu, X., Zhao, Y., Wei, J., Yi, C., Chen, S., Li, E., et al. (2025) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2025.100148 · Cited by 4
Explorando la Enfermedad de Alzheimer: conocimiento actual y perspectivas futuras
Calvo, A. A. (2024) · UCrea (University of Cantabria)
Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer’s glucose impairment
Upadhyay, R., Santhosh, S., Malathi, R., Kumari, P. S., Vijayanand, S., & Sevanan, M. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.010
Brain-gut communication and potential applications of microecological treatments in stroke
Gao, M., Zhou, Y., Zhang, K., Ye, Y., Han, Z., Chen, Q., Shi, W., & Lu, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1799890
“The bile acids can activate the FXR pathway to promote expression of antimicrobial defense genes in the body, which aids protection of the gut against infection and damage, as well as prevention of pathogenic bacteria from entering blood circulation (Varesi et al., 2022).”
Chaurasiya, V., & Babre, N. (2026) · Next research. · doi:10.1016/j.nexres.2026.101755
Dynamic changes of gut microbiota during progression of three Alzheimer’s disease mice models
Zou, Z., Liu, H., Lei, D., Jian, X., & Li, X. J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1849896
“Recently, extensive studies have suggested that gut microbiota can influence the brain activity and function through the microbiota-gut-brain axis (Chen et al., 2022; Varesi et al., 2022; Wiatrak et al., 2022).”
Liang, X., Ning, T., Wang, Y., & Zhan, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1765044
“Mounting evidence now firmly links the onset of AD to an imbalance in the gut microbiota (GM) (Zhang et al., 2023; Varesi et al., 2022).”
Gut Microbiota in Alzheimer′s Disease: Mechanisms, Evidence, and Therapeutic Implications
Ramya, M., & Harshitha, B. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/4510434
Huzaifa, M. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7208440
Chen, J., Chen, X., Yu, W., Chen, T., Liu, Z., & Hu, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1933454
Effect of dietary patterns on biomarkers in Alzheimer’s disease
Rezaeimanesh, N., Khodadadi, S., Montazeri‐Shatouri, R., Motahar, A. A., Hosseini, E., Owji, M., Negah, S. S., & Moghadasi, A. N. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.012
Gunasekaran, S. K., K., H. K. C., Gobinath, M., Roychowdhury, P., & Manjula, S. N. (2026) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-026-00647-5
“Multi-omics approaches that include transcrip - tomics, phosphoproteomics, and chromatin accessibility related profiling in trehalose-treated AD models could assist in identifying coordinated pathway changes that are currently uncovered by single-marker studies [ 16, 80–82].”
DOENÇA DE ALZHEIMER E SUA RELAÇÃO COM A MICROBIOTA INTESTINAL: UMA REVISÃO DE LITERATURA
Saez, L. D., & Gagliani, L. H. (2025) · UNILUS Ensino e Pesquisa
Zhang, B., Brown, R., Bayer, A. J., Waring, J., Morgan, B. P., Marchesi, J. R., & Zhou, Y. (2026) · MedComm · doi:10.1002/mco2.71045
“First, findings show striking inconsistency in bacterial taxa and metabolic signatures across cohorts [ 20–22 ].”
Çelik, M. N., Mohammadzadeh, M., AHISKALI, M., Us, N. C., & Söğüt, M. Ü. (2026) · Current Nutrition Reports · doi:10.1007/s13668-026-00812-x
“Although findings from human studies are more heterogeneous, promising results have been reported, particularly in early disease stages [155, 159, 167, 169, 171].”
Decoding the Gut-Brain Axis: Implications for Neurodegenerative Disease Therapies
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8753-9
Song, M., Liu, A., Liang, H., Yang, Q., Zhang, B., Cui, J., & Qiu, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1817059
Sokólska, W., & Orywal, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219955
Metadata
- Authors
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A.
- Affiliations
- University of Pavia (IT)
- University of Lancashire (GB)
- Université Libre de Bruxelles (BE)
- Policlinico San Matteo Fondazione (IT)
- Council for Nutritional and Environmental Medicine (NO)
- University of Verona (IT)
- Corresponding author
- Varesi, Angelica
- Ricevuti, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-02-05
- Volume
- 14
- Issue
- 3
- Pages
- 668
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8840394
- OpenAlex
- W4210475085
- Cited by
- 225
- References
- 248
- Citations by year
- 2026: 24 · 2025: 54 · 2024: 68 · 2023: 53 · 2022: 26
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Pavia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- gut microbiota, Alzheimer's disease, gut-brain axis, dysbiosis, neurodegeneration, microbiota-based therapy, prebiotics, probiotics, fecal microbiota transplantation, diet, early diagnosis, disease progression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Humans, Prebiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.